AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 104 transactions totaling $483.7M, demonstrating a bearish sentiment with -$304.4M in net insider flow. The most recent transaction on Jan 1, 2026 involved a transaction of 539,265 shares valued at $0.
ABCL Insider Activity Summary
Who Is Buying ABCL Stock?
No significant insider buying has been recorded for ABCL in the recent period.
Who Is Selling ABCL Stock?
No significant insider selling has been recorded for ABCL in the recent period.
Is AbCellera Biologics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ABCL is bearish with an Insider Alignment Score of 19/100 and a net flow of -$304.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ABCL Frequently Asked Questions
Understanding ABCL Insider Activity
Insider trading at AbCellera Biologics Inc. (ABCL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ABCL stock, having executed 104 transactions in the past 90 days. The most active insider is Holdings Ltd. Thermopylae (Executive), who has made 16 transactions totaling $154.6M.
Related Tools
Track AbCellera Biologics Inc. Insider Activity
Get notified when executives and directors at ABCL file new Form 4 transactions